Global Apheresis Market Report and Forecast 2024-2032

Global Apheresis Market Outlook

The global apheresis market size was about USD 2.68 billion in 2023, driven by the growing demand for blood components for transfusion across the globe. The market share is anticipated to grow at a CAGR of 9.2% during the forecast period of 2024-2032 to achieve a value of USD 5.91 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America Accounts for a Significant Share in the Global Apheresis Industry

North America is one of the leading regions in the global apheresis industry. The development of this market in North America has been driven by the growing technological advancements, increased opportunities for apheresis drugs, and the prevalence of a large number of people suffering from various chronic diseases. Another significant market for the product is Europe, which is followed by the Asia Pacific. Meanwhile, the Asia Pacific is expected to witness a healthy growth in the forecast period. The Asia Pacific apheresis industry is growing due to the rising demand for various blood components for patients, rapid advancements in the region’s healthcare system, and rising healthcare spending. Furthermore, the rising prevalence of leukaemia has been one of the major reasons for the growth of the market.

Apheresis: Market Segmentation

Apheresis is a surgical technique that requires taking a donor's or a patient's entire blood and splitting it into different components so that one component can be extracted. The leftover blood products are first reintroduced into the patient's or donor's bloodstream. The separation of the component involves two processes namely centrifugation and filtration.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The apheresis industry can be categorised by product into:

• Devices
• Disposables

The various technologies associated with apheresis include:

• Centrifugation
• Membrane Separation

The classification of apheresis according to the procedure is as follows:

• Plasmapheresis
• Leukapheresis
• Erythrocytapheresis
• Plateletpheresis
• Others

The applications of apheresis are as follows:

• Renal diseases
• Haematological diseases
• Autoimmune diseases
• Neurological diseases
• Others

The regional markets for apheresis can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increased Demand for Blood Components Bolstering the Apheresis Industry Growth

The increase in demand for blood components across the world and the increased government efforts to encourage blood donation are the major factors driving the global apheresis industry forward. Acute disseminated encephalomyelitis, autoimmune haemolytic anaemia, and cardiac neonatal lupus are among the latest apheresis signs that have recently been authorised. The growing demand for various blood components, the complexity of surgical operations, and an increase in the number of injuries around the world have all led to the market's expansion. The lack of qualified practitioners and risks associated with the apheresis process, on the other hand, are likely to stifle market development. Over the forecast period, the increased demand for plasma-derived pharmaceuticals is expected to present lucrative prospects for business growth.

Key Industry Players in the Global Apheresis Market

The report gives a detailed analysis of the following key players in the global apheresis market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Nikkiso Co., Ltd.
• Asahi Kasei Medical Co. Ltd
• B. Braun Melsungen AG
• Fresenius SE & Co. KGaA
• Terumo Bct, Inc
• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report